Company Overview of Oncoral Pharma ApS
Oncoral Pharma ApS develops pharmaceutical preparation for the treatment of colon and rectal cancer patients. The company was founded in 2013 and is headquartered in Ballerup, Denmark. As of September 14, 2017, Oncoral Pharma ApS operates as a subsidiary of CMC Contrast AB.
Founded in 2013
Key Executives for Oncoral Pharma ApS
Oncoral Pharma ApS does not have any Key Executives recorded.
Similar Private Companies By Industry
|7TM Pharma A/S||Europe|
|Acesion Pharma ApS||Europe|
|Action Pharma A/S||Europe|
|Adenium Biotech ApS||Europe|
Recent Private Companies Transactions
September 14, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Oncoral Pharma ApS, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.